Recombinant multi-species FCRL2/CD307b protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine FCRL2/CD307b protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a member of the immunoglobulin receptor superfamily and is one of several Fc receptor-like glycoproteins clustered on the long arm of chromosome 1. The encoded protein has four extracellular C2-type immunoglobulin domains, a transmembrane domain and a cytoplasmic domain that contains one immunoreceptor-tyrosine activation motif and two immunoreceptor-tyrosine inhibitory motifs. This protein may be a prognostic marker for chronic lymphocytic leukemia. Alternatively spliced transcript variants have been described, but their biological validity has not been determined. [provided by RefSeq, Apr 2009]
The Alternative Names of target: 2810439C17Rik,9330158F12,CD307b,FCRH2,FCRL2,FCRL3,Fc receptor homolog 2 (FcRH2),Fc receptor-like protein 2,FcR-like protein 2,FcRH2sc,FcRL2,Fcrh2,Fcrl2,Fcrls,IFGP family protein 4,IFGP2,IFGP4,IRTA4,IgSR,Immunoglobulin receptor translocation-associated protein 4,MMAN-g,Msr2,SH2 domain-containing phosphatase anchor protein 1,SPAP1,SPAP1A,SPAP1B,SPAP1C,moFcRH2sc
Go
to FCRL2/CD307b products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-IP0840-Ag-1/ GM-Tg-hg-IP0840-Ag-2 | Human FCRL2/CD307b protein | Human |
| GM-Tg-rg-IP0840-Ag-1/ GM-Tg-rg-IP0840-Ag-2 | Rat FCRL2/CD307b protein | Rat |
| GM-Tg-mg-IP0840-Ag-1/ GM-Tg-mg-IP0840-Ag-2 | Mouse FCRL2/CD307b protein | Mouse |
| GM-Tg-cynog-IP0840-Ag-1/ GM-Tg-cynog-IP0840-Ag-2 | Cynomolgus/Rhesus macaque FCRL2/CD307b protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-IP0840-Ag-1/ GM-Tg-felg-IP0840-Ag-2 | Feline FCRL2/CD307b protein | Feline |
| GM-Tg-cang-IP0840-Ag-1/ GM-Tg-cang-IP0840-Ag-2 | Canine FCRL2/CD307b protein | Canine |
| GM-Tg-bovg-IP0840-Ag-1/ GM-Tg-bovg-IP0840-Ag-2 | Bovine FCRL2/CD307b protein | Bovine |
| GM-Tg-equg-IP0840-Ag-1/ GM-Tg-equg-IP0840-Ag-2 | Equine FCRL2/CD307b protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-IP0840-Ag-1/ GM-Tg-hg-IP0840-Ag-2;
GM-Tg-rg-IP0840-Ag-1/ GM-Tg-rg-IP0840-Ag-2;
GM-Tg-mg-IP0840-Ag-1/ GM-Tg-mg-IP0840-Ag-2; GM-Tg-cynog-IP0840-Ag-1/ GM-Tg-cynog-IP0840-Ag-2; GM-Tg-felg-IP0840-Ag-1/ GM-Tg-felg-IP0840-Ag-2; GM-Tg-cang-IP0840-Ag-1/ GM-Tg-cang-IP0840-Ag-2; GM-Tg-bovg-IP0840-Ag-1/ GM-Tg-bovg-IP0840-Ag-2; GM-Tg-equg-IP0840-Ag-1/ GM-Tg-equg-IP0840-Ag-2 |
| Products Name | FCRL2/CD307b protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | FCRL2/CD307b |
| Protein Sub-location | Introcelluar Protein |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine FCRL2/CD307b protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.